lyophilized powder comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-06-08. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Calculated for the acetylated heptapeptide |
| Molecular weight | ~889 Da | Monoisotopic mass approximately 889.0 Da |
| Amino acid sequence | Ac-LKKTETQ | N-terminal acetylated seven-residue peptide |
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid |
| Solubility class | Water-soluble | Peptides of this size generally dissolve in aqueous media |
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
In a ring-opening, the cleaved molecule remains as a single unit. The bond breaks, but the two fragments remain attached by other parts of the structure. For example, an epoxide ring can be opened by heterolytic cleavage of one of the polar carbon–oxygen bonds to give a single acyclic structure.
Methods of nuclear spectroscopy use properties of a nucleus to probe a material's properties, especially the material's local structure. Common methods include nuclear magnetic resonance spectroscopy (NMR), Mössbauer spectroscopy (MBS), and perturbed angular correlation (PAC).
Plastination is a technique used in anatomy to conserve bodies or body parts. The water and fat are replaced by certain plastics, yielding specimens that can be touched, do not smell or decay, and even retain most microscopic properties of the original sample. The technique was invented by Gunther von Hagens when working at the anatomical institute of the Heidelberg University in 1978. Von Hagens patented the technique in several countries and was heavily involved in its promotion, especially as the creator and director of the Body Worlds traveling exhibitions, exhibiting plastinated human bodies internationally. He also founded and directed the Institute for Plastination in Heidelberg. More than 40 institutions worldwide have facilities for plastination, mainly for medical research and study, and most affiliated to the International Society for Plastination.
=== Education === Newsom joined Long Beach City College Superintendent Eloy Oakley in a November 2015 op-ed calling for the creation of the California College Promise, which would create partnerships between public schools, public universities, and employers and offer a free community college education. Throughout 2016, he joined Oakland mayor Libby Schaaf at the launch of the Oakland Promise and Second Lady Jill Biden and Los Angeles mayor Eric Garcetti at the launch of the LA Promise. In June 2016, Newsom helped secure $15 million in the state budget to support the creation of promise programs throughout the state. In December 2015, Newsom called on the University of California to reclassify computer science courses as a core academic class to incentivize more high schools to offer computer science curricula. He sponsored successful legislation signed by Governor Brown in September 2016, that began the planning process for expanding computer science education to all state students, beginning as early as kindergarten. In 2016, Newsom led an effort to enact a series of reforms at the University of California to give student-athletes additional academic and injury-related support, and to ensure that contracts for athletic directors and coaches emphasized academic progress. This came in response to several athletics programs, including the University of California–Berkeley's football team, which had the lowest graduation rates in the country.
Sources: en.wikipedia.org
Mendelevium is a synthetic chemical element; it has symbol Md (formerly Mv) and atomic number 101. A metallic radioactive transuranium element in the actinide series, it is the first element by atomic number that currently cannot be produced in macroscopic quantities by neutron bombardment of lighter elements. It is the thirteenth actinide, the ninth transuranic element, and the first transfermium; it is named after Dmitri Mendeleev, the father of the periodic table. Like all the transfermiums, it can only be produced in particle accelerators by bombarding lighter elements with charged particles. The element was first produced in 1955 by bombarding einsteinium with alpha particles, the method still used today. Using commonly-available microgram quantities of einsteinium-253, over a million mendelevium atoms may be made each hour. The chemistry of mendelevium is typical for the late actinides, with a dominant +3 oxidation state but also a +2 oxidation state accessible in solution. All known isotopes of mendelevium have short half-lives; there are currently no uses for it outside basic scientific research, and only small amounts are produced.
Flying Officer (now Acting Wing Commander) Robert Charles Timothy, Royal Air Force, 30389992. Civil Enass Abo Hamed. Co-Founder and Chief Executive Officer, H2GO Power. For services to Engineering and to Enterprise. Dr. Helen Mary Abrahams (Helen Pain). Chief Executive, Royal Society of Chemistry and lately Chair, Board of Trustees, Science Council. For services to Science. Sheila Ann Abrahams. Founder, Freelance Hairdressers' Association. For services to the Hairdressing Industry. Gerald Ronald Joseph Adams. For voluntary services to the community in Barry, Glamorgan. Bayo Adelaja. Founder and Chief Executive Officer, Do It Now Now. For services to Social Mobility, to Financial Inclusion and to Entrepreneurship. Dr. Olurotimi Babatunde Adesanya. Founder and Chair, African and Caribbean Dental Association UK and Principal Dentist, Watling Street Dental Care. For services to Oral Health. Taslima Parveen Ahmad. Founder, Creative Design and Manufacture UK. For services to Disadvantaged People and to the Minority Ethnic Community. Shabnam Ahmed Butt. Lead for Adult Safeguarding, Camden London Borough Council. For services to Social Care. Jill Alcock (Jill Clewes). Founder, Jill Clewes Academy for Theatre Arts. For services to the Arts and to Charity. Michael Allen. Principal, Lisneal College. For services to Education. Ethel Gloria Anderson. For services to the community in St Ann's, Nottingham. Samuel James Anderson. Founder and Chief Executive, IceMOS Technology. For services to Economic Development in Northern Ireland. Colin Trevor Whitney Angel.
== Other activities == While in college, Conway was a member of the Ursinius Meistersingers vocal music group, and the performing arts honor society Pi Nu Epsilon. He became a volunteer for the American Red Cross Disaster Service in 1989, but quit in 1998 due to his perception of high-level corruption in the organization. He was an Emergency Management Coordinator while residing in Malvern, Pennsylvania. In March 1990, Conway became an experimental bone marrow donor for Mark Stevenson, a 4-year-old with Hunter syndrome. The operation was the first of its kind involving an unrelated donor, and was successful; Mark lived to 24. Conway became an active volunteer for the National Marrow Donor Program, claiming to have helped add over 500 entries to their donor registry. Since May 1996, Conway has participated in the MadSci Network, a free question-and-answer Ask-A-Scientist forum organized by the medical school of Washington University in St. Louis. While most active in the period 1997–2000, he remains a member as of 2009.
This results in adrenal suppression and atrophy and, upon glucocorticoid discontinuation, temporary adrenal insufficiency. Similarly, CPA both in animals and humans can weakly reduce ACTH and cortisol levels and decrease adrenal gland weight as well as cause adrenal insufficiency with discontinuation. These findings suggest that CPA possesses weak glucocorticoid properties. CPA has been reported to be an antagonist of the glucocorticoid receptor (GR) in vitro and may reduce adrenal cortisol and corticosterone production by weakly inhibiting the enzymes 3β-hydroxysteroid dehydrogenase and 21-hydroxylase. These are antiglucocorticoid actions. However, metabolites of CPA, for instance 15β-hydroxycyproterone acetate, may have differing activities. Both cyproterone and CPA have been found to possess glucocorticoid effects, and based on studies in mice, it has been suggested that CPA has approximately one-fifth of the potency of prednisone as a glucocorticoid. The glucocorticoid effects of CPA in humans appear to be less significant than those in animals. Megestrol acetate, medroxyprogesterone acetate, and chlormadinone acetate are all steroidal progestins of the 17α-hydroxyprogesterone family and close analogues of CPA which similarly possess glucocorticoid properties and the potential for producing adrenal insufficiency upon discontinuation.
The Fat Duck is a fine dining restaurant in Bray, Berkshire, England, owned by the chef Heston Blumenthal. Housed in a 16th-century building, the Fat Duck opened on 16 August 1995. Although it originally served food similar to a French bistro, it soon acquired a reputation for precision and innovation, and has been at the forefront of many modern culinary developments, such as food pairing, flavour encapsulation and multi-sensory cooking. The number of staff in the kitchen increased from four when the Fat Duck opened to 42, resulting in a ratio of one kitchen staff member per customer. The Fat Duck gained its first Michelin star in 1999, its second in 2002 and its third in 2004, making it one of eight restaurants in the UK to earn three Michelin stars. In 2005, the World's 50 Best Restaurants named the Fat Duck the best restaurant in the world. It lost its stars in 2016 when it closed for renovation, but regained all three the following year. The Fat Duck is known for its tasting menu featuring dishes such as nitro-scrambled egg and bacon ice cream, an Alice in Wonderland–inspired mock turtle soup involving a bouillon packet made up to look like a fob watch dissolved in tea, and a dish called Sound of the Sea which includes an audio element. It has an associated laboratory where Blumenthal and his team develop new dish concepts. In 2009, the Fat Duck suffered from the largest norovirus outbreak ever documented at a restaurant, with more than 400 diners falling ill.
Sources: en.wikipedia.org
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.
No. Thymosin beta-4 is a 43-amino-acid protein, while TB-500 represents only a short N-terminal segment. The two should not be treated as interchangeable in experimental design.
It is often called a thymosin beta-4 fragment, Tβ4 fragment, or Ac-LKKTETQ. The name TB-500 is mainly a commercial or catalog label rather than a formal chemical name.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.